Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant human C1-inhibitor

EU orphan designation number: EU/3/01/036
Active ingredient: Recombinant human C1-inhibitor
Indication: Treatment of angioedema caused by C1 inhibitor deficiency
Sponsor: Pharming Group N.V.
Archimedesweg 4, NL-2333 CN Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/05/2001 Orphan designation EMEA/OD/053/00 (2001)1199 of 11/05/2001
02/12/2002 Transfer of orphan designation EMEA/OD/053/00/T/01 (2002)4753 of 29/11/2002
17/09/2010 Removal of orphan designation from Community Register